September 20, 2017
Barcelona, Spain
ESSD
European Society for Swallowing Disorders
20.09. - 23.09.2017
September 20, 2017
Nice, France
EUGMS
European Union Geriatric Medicine Society
20.09 - 22.09.2017
September 09, 2017
The Hague, The Netherlands
ESPEN
European Society for Clinical Nutrition and Metabolism
09.09. - 12.09.2017
September 08, 2017
Madrid, Spain
ESMO - Europe
European Society for Medical Oncology
08.09. - 12.09.2017
June 17, 2017
Copenhagen, Denmark
ISBT - Europe
International Society of Blood Transfusion
17.06. - 21.06.2017
June 03, 2017
Madrid, Spain
ERA-EDTA
54th Congress of European Diaysis and Transplant Association
03.06. - 07.06.2017
- No conditions by Spanish antitrust authority
- Closing of transaction expected by January 31, 2017
Fresenius Helios today received antitrust approval to acquire Quirónsalud, Spain’s largest private hospital operator. The relevant Spanish antitrust authority has approved the transaction without imposing conditions. The acquisition can therefore be closed by January 31, 2017. Quirónsalud will be consolidated as of February 1, 2017.
Quirónsalud’s network is comprised of 43 hospitals, 39 outpatient centers and around 300 Occupational Risk Prevention (“ORP”) centers located in all economically important areas in Spain. The company has about 35,000 employees and offers the full spectrum of inpatient and outpatient care. With the acquisition, Fresenius Helios strengthens its position as Europe’s largest private hospital operator.
Given the expected meaningful accretion to Group sales and earnings, Fresenius will publish new mid-term targets as part of its full-year 2016 reporting.
This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.
May 17, 2017
Copenhagen, Denmark
ISFA
11th International Society for Apheresis Congress
17.05. - 20.05.2017
May 10, 2017
Prague, Czech Republic
ESPGHAN
European Society for Paediatric Gastroenterology, Hepatology and Nutrition
10.05. - 13.05.2017